Breztri Aerosphere

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:temple
gptkb:Glaxo_Smith_Kline
gptkbp:activities anti-inflammatory and bronchodilator effects
gptkbp:appointed_by inhalation
gptkbp:approves gptkb:2019
gptkbp:availability prescription only
gptkbp:clinical_trial Phase III
asthma management
COPD management
studied in clinical trials
gptkbp:contains gptkb:budesonide
gptkb:formoterol
gptkbp:contraindication hypersensitivity to components
gptkbp:dosage_form aerosol
gptkbp:duration long-term use
gptkbp:effective_date FDA approved
gptkbp:formulation combination therapy
https://www.w3.org/2000/01/rdf-schema#label Breztri Aerosphere
gptkbp:indication maintenance treatment of COPD
gptkbp:ingredients gptkb:budesonide
gptkb:formoterol_fumarate
gptkbp:interacts_with MAO inhibitors
diuretics
beta-blockers
gptkbp:invention patented
gptkbp:is_effective_against improves quality of life
improves lung function
reduces exacerbations
gptkbp:is_used_for chronic obstructive pulmonary disease
gptkbp:label prescribing information available
gptkbp:manager inhalation
gptkbp:manufacturer gptkb:temple
gptkbp:marketed_as gptkb:Breztri
multiple countries
gptkbp:packaging pressurized metered-dose inhaler
gptkbp:pharmacokinetics excreted in urine
metabolized in the liver
systemic absorption
gptkbp:population adults
children over 12 years
gptkbp:price varies by region
gptkbp:provides_information_on included in COPD treatment guidelines
included in asthma treatment guidelines
gptkbp:research ongoing studies for new indications
gptkbp:safety_features generally well tolerated
gptkbp:side_effect gptkb:healthcare_organization
dizziness
fatigue
headache
nausea
cough
sinusitis
throat irritation
upper respiratory tract infection
oral thrush
gptkbp:storage store at room temperature
gptkbp:type_of_care important for effectiveness